Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones

British Journal of Anaesthesia

Volumn 94, Issue 4, 2005, Pages 479-485

  Dinse, A ^a   Föhr, Karl J ^a   Georgieff, M ^a   Beyer, C ^b   Bulling, A ^c   Weigt, H U ^a  

^a Clinic for Anesthesiology   (Germany)

^b Department of Anatomy ^*  (Germany)

^c Flyion GmbH   (Germany)

Author keywords

Amino acid, NMDA; Anaesthetics volatile, xenon; Measurement techniques, electrophysiology; Model, brain cortical neurones; Model, neuroblastoma cells; Pharmacology, glutamate ligand gated ion channel; Receptors; Receptors, amino acid, AMPA; Receptors, amino acid, kainate

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; XENON;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; FEMALE; GENETIC TRANSFECTION; INHIBITION KINETICS; MEMBRANE CURRENT; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 17044433904     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aei080     Document Type: Article

References (45)

1. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998; 396: 324
2. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003; 91: 709-17
3. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65 443-52
4. Hapfelmeier G, Zieglgansberger W, Haseneder R, Schneck H, Kochs E. Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors. Anesth Analg 2000; 91 1542-9
5. deSousa S, Dickinson R, Lieb W, Franks N. Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 2000; 92: 1055-66
6. Dingledine R, Borges K, Bowie D, Traynelis S. The glutamate receptor ion channels. Pharmacol Rev 1999; 51: 7-58
7. Franciosi S. AMPA receptors: potential implications in development and disease. Cell Mol Life Sci 2001; 58: 921-30
8. Lerma J, Paternain AV, Rodriguez-Moreno A, Lopez-Garcia JC. Molecular physiology of kainate receptors. Physiol Rev 2001; 81 971-98
9. Pogatzki EM, Zahn PK, Brennan TJ. Effect of pretreatment with intrathecal excitatory amino acid receptor antagonists on the development of pain behavior caused by plantar incision. Anesthesiology 2000; 93: 489-96
10. Pogatzki EM, Niemeier JS, Sorkin LS, Brennan TJ. Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision. Pain 2003; 105: 97-107
11. Sonner JM, Antognini JF, Dutton RC, et al. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg 2003; 97: 718-40
12. Takeda A, Minami A, Seki Y, Oku N. Differential effects of zinc on glutamatergic and GABAergic neurotransmitter systems in the hippocampus. J Neurosci Res 2004; 75: 225-9
13. Fournier GN, Materi LM, Semba. K, Rasmusson DD. Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain. Neuroscience 2004; 123: 785-92
14. David HN, Sissaoui K, Abraini JH. Modulation of the locomotor responses induced by D(1)-like and D(2)-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens. Neuropharmacology 2004; 46: 179-91
15. Bleakman D, Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 1998; 37: 1187-204
16. Lippert K, Welsch M, Krieglstein J. Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Eur J Pharmacol 1994; 253: 207-13
17. Loscher W, Rundfeldt C, Honack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur J Neurosci 1993; 5: 1545-50
18. Westergren I, Johansson BB. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema. Brain Res 1992; 573: 324-6
19. Pettigrew LC, Holtz ML, Minger SL, Craddock SD. Glutamate receptor antagonists modulate heat shock protein response in focal brain ischemia. Neurol Res 2003; 25: 201-7
20. David HN, Leveille F, Chazalviel L, et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003; 23: 1168-73
21. de Sousa SLM, Dickinson R, Lieb WR, Franks NP. Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 2000; 92: 1055-66
22. Plested AJ, Wildman SS, Lieb WR, Franks NP. Determinants of the sensitivity of AMPA receptors to xenon. Anesthesiology 2004; 100: 347-58
23. Wood M, VanDongen H, VanDongen A. Structural conservation of ion conduction pathways in K channels and glutamate receptors. Proc Natl Acad Sci USA 1995; 92: 4882-6
24. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991; 354: 31-7
25. Paternain AV, Rodriguez-Moreno A, Villarroel A, Lerma J. Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology 1998; 37: 1249-59
26. Lerma J, Paternain AV, Naranjo JR, Mellstrom B. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci USA 1993; 90: 11688-92
27. Partin KM, Patneau DK, Mayer ML. Cyclothiazide differently modulates desensitization of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol Pharmacol 1994; 46: 129-138
28. Stern-Bach Y, Russo S, Neuman M, Rosenmund C. A point mutation in the glutamate binding site blocks desensitization of AMPA receptors. Neuron 1998; 21: 907-18
29. Sobolevsky AI. Channel block of glutamate receptors. Recent Res Dev Physiol 2003; 1: 1-38
30. Franks NP, Dickinson R, de Sousa SLM, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998; 396: 324
31. Weigt HU, Georgieff M, Beyer C, Wachter U, Föhr KJ. Xenon incorporated in a lipid emulsion inhibits NMDA receptor channels. Acta Anaesthesiol Scand 2003; 47: 1119-24
32. Parsons CG, Gruner R, Rozental J. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Neuropharmacology 1994; 33: 589-604
33. Dai WM, Egebjerg J, Lambert JCD. Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal neurons and their correlation to the expression of glutamate receptor subunits, GluR1-4. Br J Pharmacol 2001; 132: 1859-75
34. Brodin L, Shupliakov O. Functional diversity of central glutamate synapses-pre- and post-synaptic mechanisms. Acta Physiol Scand 1994; 150: 1-10
35. Löscher W, Rundfeldt C, Hönack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor NBQX in the kindling model of epilepsy. Eur J Pharmacol 1993; 5: 1545-50
36. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003; 91: 709-17
37. Lynch CI, Baum J, Tenbrinck R. Xenon anesthesia. Anesthesiology 2000; 92: 865-8
38. McFarlane C, Warner DS, Todd MM, Nordholm L. AMPA receptor competitive antagonism reduces halothane MAC in rats. Anesthesiology 1992; 77: 1165-70
39. Willets J, Balster R, Leander J. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 1990; 11: 423-8
40. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002; 89: 739-46
41. Regan R, Choi D. Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 1991; 43: 585-91
42. Regan FR. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci Lett 1996; 213: 9-12
43. Ikonomidou C, Turski L. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab Brain Dis 1996; 11: 125-41
44. Hylton C, Perri BR, Voddi MD. Non-NMDA antagonists GYKI-52466 enhances spatial memory after experimental brain injury. J Neurotrauma 1995; 12: 124
45. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98: 690-8